Channel Medsystems, Inc.
USPTO PatentsView assignee record - 31 granted patents across 4 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Channel ranks #9,998 of 49,997 tracked US assignees by granted-patent volume, with 31 patents across 4 technology areas.
- #9,998
- of 49,997 US assignees by volume
- Top 38%
- by Innovation Score (39.4/100)
- 19.0
- avg claims per patent
- -33%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R9998 · US Corporation #9,998 · 31 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL
- GRANTS-SMALL 31 grants
- UPPER-Q #9,998/49,997
- PHOTO-FINISH Calysta
- CPC-NARROW A61B · 4 areas
- INNOV-THIN 39.4/100
- CLAIMS-RICH 19.0 claims/avg
- TYPE-USCORP US Corporation
- VEL-DOWN -33% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Calysta, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Channel’s 39.4 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Channel
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Channel Medsystems · this assignee
Channel Medsystems · this assignee
39 score
- Mimecast Services · near
Mimecast Services · near
39 score
- Molo Design · near
Molo Design · near
39 score
- Project Phoenix · near
Project Phoenix · near
39 score
- uBiome · near
uBiome · near
39 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Channel's Innovation Score is 39.4/100 (top 38% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Channel?
Each dot is one of Channel’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Channel’s own 19.0 claims/patent is ABOVE the 17.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Channel's grants concentrate
Channel Medsystems, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 96.8% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2016 (11 grants) versus a trough of 1 in 2021. By volume, Channel sits between Calysta, Inc. and Dehn SE.
Channel's three-year grant acceleration
Channel Medsystems, Inc. shows 8 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Channel's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Calysta
Calysta, Inc.
31 patents
- Cardiac Dimension…
Cardiac Dimensions Pty. Ltd.
31 patents
- Cardioxyl Pharmac…
Cardioxyl Pharmaceuticals, Inc.
31 patents
- Celestial AI
Celestial AI Inc.
31 patents
- Chrysler Group
Chrysler Group LLC
31 patents
- Crane &
Crane & Co., Inc.
31 patents
- Crystal Lagoons
Crystal Lagoons Technologies, Inc.
31 patents
- Dehn SE
Dehn SE
31 patents
- Channel Medsystems ◀
Channel Medsystems, Inc.
31 patents
What this shows Channel holds 31 patents at rank #10,006, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Channel
By rank, the assignees closest to #10,006 in granted patent volume.
- Calysta, Inc. #10,002 · 31 patents
- Cardiac Dimensions Pty. Ltd. #10,003 · 31 patents
- Cardioxyl Pharmaceuticals, Inc. #10,004 · 31 patents
- Celestial AI Inc. #10,005 · 31 patents
- Chrysler Group LLC #10,007 · 31 patents
- Crane & Co., Inc. #10,008 · 31 patents
- Crystal Lagoons Technologies, Inc. #10,009 · 31 patents
- Dehn SE #10,010 · 31 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Channel's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Channel, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Channel ranks #624 of 7,127 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (39 here).
Channel's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
39 Top 38% higher than 62% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 11 | 35.5% |
| 2017 | 3 | 9.7% |
| 2018 | 2 | 6.5% |
| 2019 | 2 | 6.5% |
| 2020 | 3 | 9.7% |
| 2021 | 1 | 3.2% |
| 2022 | 1 | 3.2% |
| 2023 | 4 | 12.9% |
| 2024 | 3 | 9.7% |
| 2025partial year | 1 | 3.2% |
Which technologies does Channel Medsystems, Inc. patent most?
Top 4 of 4 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Channel Medsystems, Inc.'s patent record in context - here's where to go next.
- Channel Medsystems, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 96.8% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #9,998 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Channel Medsystems, Inc. against Calysta, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 39.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.